MRT5410
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRT5410, covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older [Phase 1, Phase 2]